No takes yet. Share an insight, caveat, or question.
Randomized trial demonstrates improved antitumor efficacy and immune response in solid tumors using modified CAR-T cells, suggesting a new treatment strategy.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: